Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza

NCT01068912 is registered in ClinicalTrials.gov with MDVI, LLC as lead sponsor.

NCT NCT01068912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01068912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Favipiravir in Adult Patients With Uncomplicated Influenza
Lead sponsor
MDVI, LLC
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2010
Completion date
May 31, 2012
Enrollment
530 (actual)
Sites
228

Conditions

As the registry lists them; a condition with its own page is linked.

influenza